DE602005014481D1 - Verwendung des Neutrophil-activating-protein von Helicobacter pylori und/oder Teile davon als Adjuvant für die Induktion einer T-helper type 1 (TH1) Immunantwort - Google Patents

Verwendung des Neutrophil-activating-protein von Helicobacter pylori und/oder Teile davon als Adjuvant für die Induktion einer T-helper type 1 (TH1) Immunantwort

Info

Publication number
DE602005014481D1
DE602005014481D1 DE602005014481T DE602005014481T DE602005014481D1 DE 602005014481 D1 DE602005014481 D1 DE 602005014481D1 DE 602005014481 T DE602005014481 T DE 602005014481T DE 602005014481 T DE602005014481 T DE 602005014481T DE 602005014481 D1 DE602005014481 D1 DE 602005014481D1
Authority
DE
Germany
Prior art keywords
responses
helicobacter pylori
adjuvant
nap
activating protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005014481T
Other languages
English (en)
Inventor
Prete Gianfranco Del
Elios Mario Milco D
Amedeo Amedei
Andrea Cappon
Bernard Marina De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BERNARD MARINA DE
Original Assignee
BERNARD MARINA DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BERNARD MARINA DE filed Critical BERNARD MARINA DE
Publication of DE602005014481D1 publication Critical patent/DE602005014481D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005014481T 2005-09-23 2005-09-23 Verwendung des Neutrophil-activating-protein von Helicobacter pylori und/oder Teile davon als Adjuvant für die Induktion einer T-helper type 1 (TH1) Immunantwort Active DE602005014481D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05425666A EP1767214B1 (de) 2005-09-23 2005-09-23 Verwendung des Neutrophil-activating-protein von Helicobacter pylori und/oder Teile davon als Adjuvant für die Induktion einer T-helper type 1 (TH1) Immunantwort

Publications (1)

Publication Number Publication Date
DE602005014481D1 true DE602005014481D1 (de) 2009-06-25

Family

ID=36113801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005014481T Active DE602005014481D1 (de) 2005-09-23 2005-09-23 Verwendung des Neutrophil-activating-protein von Helicobacter pylori und/oder Teile davon als Adjuvant für die Induktion einer T-helper type 1 (TH1) Immunantwort

Country Status (4)

Country Link
EP (1) EP1767214B1 (de)
AT (1) ATE431156T1 (de)
DE (1) DE602005014481D1 (de)
WO (1) WO2007039451A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025429A1 (en) 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
EP3512537B1 (de) * 2016-09-15 2023-11-01 Elicera Therapeutics AB T-zell-immuntherapie
US20220096595A1 (en) * 2019-01-30 2022-03-31 Zhengzhou University Anti-atopic dermatitis protein
WO2021245611A1 (en) 2020-06-05 2021-12-09 Glaxosmithkline Biologicals Sa Modified betacoronavirus spike proteins
CA3213646A1 (en) 2021-04-23 2022-10-27 Di YU Adenovirus for treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
EP1073745B1 (de) * 1998-04-30 2004-12-01 Chiron S.r.l. Verfahren zur immunisierung und behandlung von h. pylori infektion
GB9914960D0 (en) * 1999-06-25 1999-08-25 Chiron Spa Delivery system
GB0029919D0 (en) * 2000-12-07 2001-01-24 Chiron Spa Helicobacter pylori prime & boost vaccination
EP1423142A1 (de) * 2001-08-31 2004-06-02 Chiron SRL. Helicobacter pylori impfung mit einer kombination der proteine caga, vaca und nap

Also Published As

Publication number Publication date
EP1767214B1 (de) 2009-05-13
ATE431156T1 (de) 2009-05-15
EP1767214A1 (de) 2007-03-28
WO2007039451A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
ES2485316T3 (es) Usos inmunológicos de compuestos inmunomoduladores para vacunas y terapia anti-enfermedades infecciosas
IS6895A (is) Aðferð til að bera kennsl á, einangra og vinna mótefnavaka við ákveðnum sjúkdómsvaldi
DE602005014481D1 (de) Verwendung des Neutrophil-activating-protein von Helicobacter pylori und/oder Teile davon als Adjuvant für die Induktion einer T-helper type 1 (TH1) Immunantwort
DE602004028468D1 (de) Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke
ATE366586T2 (de) Modifizierte variante des vaccinia ankara virus als impfstoff für neugeborene
EP2385060A3 (de) Verfahren und Zusammensetzungen zum Auslösen von multivalenten Immunreaktionen gegen auf Krebszellen und Tumor-Stroma exprimierte dominante und subdominante Epitope
BR0314666A (pt) Composição nutricional ou terapêutica utilizável para o tratamento de mamìferos para aumentar a atividade imune e método de tratar um mamìfero para aumentar a concentração de glutationa no tecido no referido mamìfero
EA201391200A1 (ru) Способы и композиции для вакцинации от staphylococcus aureus
WO2006119983A3 (en) Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
DE602004028029D1 (en) Rwendung
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
MX2010001381A (es) Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos.
TR201820975A2 (tr) İbuprofen, Psödoefedrin ve Erdostein İçeren Uzatılmış Salım Sağlayan Farmasötik Kompozisyon
AR039982A1 (es) Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas
DE502004005784D1 (de) Mittel zur behandlung von infektionen mit leishmanien
ATE447968T1 (de) Impfung mit immunisolierten und einen immunomodulator produzierenden zellen
BR0213656A (pt) composição, método para a obtenção de uma resposta imune à tênia, método para vacinar um mamìfero contra tênia, vacina, método para pemitir a vacinação, métodos para a redução de perda sangüìnea, para a redução do tamanho da tênia e para a redução de aflição por tênia em um paciente infectado com tênia, antìgeno recombinante sintético e antìgeno
BRPI0407727A (pt) adjuvante de vacina de linfócito humano
TW200740997A (en) Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy
Adawa et al. Clinical trial of long‐acting oxytetracycline and piroxicam in the treatment of canine ehrlichosis
EP2530087A3 (de) Brachyspira-Sequenzen, immunogene Zusammensetzungen, Herstellungsverfahren dafür und Verwendung davon
DK1742656T3 (da) Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine
Panchal Testing of Effectiveness of the Herbal Beauty Products Against Various Skin Infections Causing Human Skin Pathogens.
RU2010118309A (ru) Способ повышения умственной работоспособности человека
Bansal et al. AND PIROXICAM IN THE TREATMENT OF CANINE EHRLICH10818

Legal Events

Date Code Title Description
8364 No opposition during term of opposition